Nanollose Ltd. (AU:NC6) has released an update. Nanollose Limited has announced the cessation of one million Series I options, which expired on September 15, 2024, without being exercised or converted.
Nanollose Ltd. (AU:NC6) has released an update. Nanollose Limited has announced the cessation of one million Series I options, which expired on September 15, 2024, without being exercised or converted.
Nanollose Ltd. (AU:NC6) has released an update. Nanollose Ltd. has taken a significant step in its commercial strategy by shipping 110kg of Nufolium-20™ fibre to Glatfelter for conversion into nonwoven
Nanollose Ltd. (AU:NC6) has released an update. Nanollose Limited, an entity listed on the ASX, has fully adhered to the Corporate Governance Council’s recommendations throughout the year ended June 30,
Nanollose Ltd. (AU:NC6) has released an update. Nanollose Limited reports a significant decrease in revenues by 67.2% and a 14.1% reduction in losses after tax for the fiscal year ended
Nanollose Ltd. (AU:NC6) has released an update. Nanollose Limited, a biomaterials company known for its eco-friendly technology, has secured a $200,000 R&D loan from Asymmetric Innovative Finance, bolstering its research